Pacer Advisors, Inc. - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 155 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Pacer Advisors, Inc. ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$39,000
-20.4%
798
-31.4%
0.00%0.0%
Q4 2020$49,000
+19.5%
1,164
+29.0%
0.00%0.0%
Q3 2020$41,000
-86.8%
902
-82.6%
0.00%
-85.7%
Q3 2019$311,000
-6.3%
5,170
+31.4%
0.01%
-12.5%
Q2 2019$332,000
+44.3%
3,936
+46.2%
0.01%
-11.1%
Q3 2018$230,000
+784.6%
2,693
+498.4%
0.01%
+350.0%
Q4 2017$26,0004500.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 862,848$42,556,00014.73%
Fairmount Funds Management LLC 171,147$8,441,0003.56%
ARMISTICE CAPITAL, LLC 1,648,000$81,279,0001.87%
FARALLON CAPITAL MANAGEMENT LLC 1,995,000$98,393,0000.49%
Jackson Creek Investment Advisors LLC 21,409$1,056,0000.37%
Hennion & Walsh Asset Management, Inc. 113,940$5,620,0000.34%
Virtus ETF Advisers LLC 14,721$726,0000.31%
Granahan Investment Management 193,416$9,539,0000.20%
Yorktown Management & Research Co Inc 4,500$222,0000.18%
JACOBS LEVY EQUITY MANAGEMENT, INC 242,257$11,948,0000.09%
View complete list of ENANTA PHARMACEUTICALS INC shareholders